• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics General Medicine Classics

The NETT: Lung-volume-reduction surgery in emphysema

byEvan ChenandAndrew Cheung, MD MBA
May 25, 2014
in General Medicine Classics, Surgery Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Lung-volume-reduction surgery significantly improves exercise capacity, but not overall survival, in patients with emphysema when compared with medical therapy

2. Post hoc subgroup analyses showed that in patients with upper-lobe emphysema and low baseline exercise capacity, lung-volume-reduction surgery significantly decreased mortality compared to medical therapy

Original Date of Publication: May 22, 2003

Study Rundown: While lung-volume-reduction surgery had been proposed as a treatment option for patients with severe emphysema, there was little evidence examining its effects. The National Emphysema Treatment Trial (NETT) was the first study to assess the morbidity, mortality, and therapeutic benefits of lung-volume-reduction surgery for emphysema patients. The findings of the trial showed that the lung-reduction significantly improved patients’ exercise capacity compared to medical therapy, but did not significantly change overall survival (RR 1.01, p=0.90). Post hoc subgroup analyses demonstrated that surgery significantly reduced mortality in patients with upper-lobe emphysema and low exercise capacity (RR 0.47, p=0.005) and significantly increased mortality in patients with non-upper-lobe emphysema and high exercise capacity (RR 2.06, p=0.02) when compared with medical treatment. A major criticism of this trial centres on the survival differences demonstrated in specific subgroups based on post hoc analyses, as opposed to predefined analyses.

In summary, results of this study suggest that lung-volume-reduction surgery can significantly improve exercise capacity in patients with emphysema. While subgroup analyses did demonstrate survival benefits in patients with upper-lobe emphysema and low exercise capacity at baseline, these findings should be interpreted with caution given that they were performed post hoc.

Click to read the study in NEJM

RELATED REPORTS

Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function

#VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

In-Depth [randomized controlled trial]: This was a randomized, controlled trial that enrolled 1,218 patients from 17 clinics from across the United States. The list of inclusion and exclusion criteria is lengthy – generally, patients were eligible if they had clinical and radiological evidence of emphysema, were non-smokers for at least 4 months, completed all pre-rehabilitation assessments, and were considered fit for surgery. Each patient’s distribution of emphysema (i.e., predominantly upper-lobe vs. predominantly non-upper-lobe) was determined by high-resolution CT. The primary outcome measures were overall mortality and maximal exercise capacity as measured by cycle ergometry. The secondary outcome measures included pulmonary function, distance walked within six minutes, and quality of life, as determined by self-administered questionnaires. Prior to randomization, patients underwent 6-10 weeks of supervised pulmonary rehabilitation. Patients were then randomly assigned to receive lung-volume-reduction surgery (i.e., bilateral stapled wedge resection via median sternotomy or video-assisted thoracic surgery) or medical therapy, and then re-evaluated after 6, 12, and 24 months of follow-up. Improved exercise capacity was defined as a 10 W increase in workload during cycle ergometry.

At 90 days, the mortality rate in the surgery group was significantly higher than the medical therapy group (7.9% vs. 1.3%, p<0.001). There was no significant difference in mortality rates when comparing patients who underwent median sternotomy and video-assisted thoracic surgery (8.6% vs. 6.1%, respectively, p=0.33). Total mortality rates were not significantly different between the two groups at a mean follow-up of 29.2 months (RR 1.01, p=0.90).  Patients receiving surgery had significantly improved exercise capacity as measured by cycle ergometry at 6 (28% vs. 4%, p<0.001), 12 (22% vs. 5%, p<0.001), and 24 months (15% vs. 3%, p<0.001) than the medical-therapy group. Post hoc subgroup analyses revealed that surgery patients with upper-lobe disease and low-exercise capacity had a lower mortality rate (RR 0.47, p=0.005) and experienced significantly improved exercise capacity (30% vs. 0%, p=0.005) when compared with similar patients receiving medical therapy only. In patients with non-upper-lobe disease and high baseline exercise capacity, mortality was significantly higher in the surgical group (RR 2.06, p=0.02).

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: copdemphysema
Previous Post

Expectant management may be appropriate in ectopic pregnancy

Next Post

Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

RelatedReports

2 Minute Medicine Rewind May 20, 2019
Pulmonology

Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function

February 24, 2021
#VisualAbstract: Cabotegravir plus rilpivirine given every 8 weeks is non-inferior to every 4 weeks for maintenance of HIV-1 viral suppression
StudyGraphics

#VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

January 6, 2021
Evidence-based interventions for pediatric asthma successfully adapted for community health centers
Infectious Disease

Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

December 27, 2020
Quick Take: The burden of health conditions for middle-aged and older adults in the United States: disability-adjusted life years
Cardiology

Quick Take: The burden of health conditions for middle-aged and older adults in the United States: disability-adjusted life years

April 22, 2019
Next Post
Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

Positive physician experience in the Pediatric AIDS Corps

Positive physician experience in the Pediatric AIDS Corps

AAP issues update on iodine deficiency and associated pollutants

AAP issues update on iodine deficiency and associated pollutants

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
  • Gratitude-focused writing may improve mental wellness during periods of chronic stress
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.